Ignace Vergote

Add Delete
Loss of copy numbers of retrotransposons ( HERVK ) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor) ‐induced phenotypes for platinum sensitivity and long‐term survival in ovarian cancer—A study from the OVCAD consortium (journal article) Fromhage, Gesa \| Obermayr, Eva \| Bednarz‐Knoll, Natalia \| Van Gorp, Toon \| Welsch, Eva \| Polterauer, Stephan \| Braicu, Elena Ioana \| Mahner, Sven \| Sehouli, Jalid \| Vergote, Ignace \| ... \| Brandt, Burkhard International Journal of Cancer, volume 155, issue 5, pages 934-945 (2024). 10.1002/ijc.34976 Cite \| Source
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance (journal article) Berckmans, Yani \| Ene, Hila M. \| Ben-Meir, Kerem \| Martinez-Conde, Antonia \| Wouters, Roxanne \| Van den Ende, Bieke \| Van Mechelen, Sara \| Monin, Roni \| Frechtel-Gerzi, Roni \| Gabay, Hila \| ... \| Palti, Yoram Frontiers in Oncology, volume 14 (2024). 10.3389/fonc.2024.1402851 Cite \| Source
Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial. (journal article) Classe, Jean-Marc \| Campion, Loic \| Lecuru, Fabrice \| Vergote, Ignace \| Jankowski, Clémentine \| Wernert, Romuald \| Pomel, Christophe \| Houvenaeghel, Gilles \| Dupre, Pierre-Francois \| Mathevet, Patrice \| ... \| Loaec, Cecile Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA5505-LBA5505 (2024). 10.1200/JCO.2024.42.17_suppl.LBA5505 Cited by (1) \| Cite \| Source
Phase 3 dose selection for selinexor in TP53 wt endometrial cancer based on exposure-response analysis. (journal article) Makker, Vicky \| Richardson, Debra L. \| Chon, Hye Sook \| Miller, David Scott \| Mau-Sørensen, Morten \| Cibula, David \| Zagouri, Flora \| Pérez Fidalgo, Alejandro \| Slomovitz, Brian M. \| Coleman, Robert L. \| ... \| Vergote, Ignace Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5594-5594 (2024). 10.1200/JCO.2024.42.16_suppl.5594 Cite \| Source
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer (journal article) Richardson, Debra L. \| Moore, Kathleen N. \| Vergote, Ignace \| Gilbert, Lucy \| Martin, Lainie P. \| Mantia-Smaldone, Gina M. \| Castro, Cesar M. \| Provencher, Diane \| Matulonis, Ursula A. \| Stec, James \| ... \| O'Malley, David M. Gynecologic Oncology, volume 185 (2024). 10.1016/j.ygyno.2024.01.045 Cited by (2) \| Cite \| Source
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – a plain language summary (journal article) González-Martín, Antonio \| Pothuri, Bhavana \| Vergote, Ignace \| Graybill, Whitney \| Lorusso, Domenica \| McCormick, Colleen C \| Freyer, Gilles \| Backes, Floor \| Heitz, Florian \| Redondo, Andrés \| ... \| Monk, Bradley J Future Oncology (2024). 10.2217/fon-2023-0782 Cited by (1) \| Cite \| Source
Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium (journal article) Obermayr, Eva \| Mohr, Thomas \| Schuster, Eva \| Braicu, Elena Ioana \| Taube, Eliane \| Sehouli, Jalid \| Vergote, Ignace \| Pujade‐Lauraine, Eric \| Ray‐Coquard, Isabelle \| Harter, Philipp \| ... \| Zeillinger, Robert International Journal of Cancer (2024). 10.1002/ijc.34978 Cite \| Source
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer (journal article) Bogani, Giorgio \| Coleman, Robert L \| Vergote, Ignace \| van Gorp, Toon \| Ray-Coquard, Isabelle \| Oaknin, Ana \| Matulonis, Ursula \| O’Malley, David \| Raspagliesi, Francesco \| Scambia, Giovanni \| Monk, Bradley J International Journal of Gynecologic Cancer, volume 34, issue 4, pages 469-477 (2024). 10.1136/ijgc-2023-004924 Cited by (6) \| Cite \| Source
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer (journal article) Gass, Paul \| Thiel, Falk C. \| Häberle, Lothar \| Ackermann, Sven \| Theuser, Anna-Katharin \| Hummel, Nadine \| Boehm, Sibylle \| Kimmig, Rainer \| Reinthaller, Alexander \| Becker, Sven \| ... \| Pöschke, Patrik Gynecologic Oncology, volume 183 (2024). 10.1016/j.ygyno.2024.03.002 Cite \| Source
1347 Prediction of lymph node metastasis in early-stage ovarian cancer: value of whole-body diffusion-weighted MRI (conference) Verbruggen, Kamiel \| Vandecaveye, Vincent \| Vergote, Ignace \| Gorp, Toon Van \| Nieuwenhuysen, Els Van \| Dresen, Raphaëla Carmen \| Broeckhoven, Valérie \| Baert, Thaïs ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.835 Cite \| Source
TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice (journal article) Berckmans, Yani \| Vankerckhoven, Ann \| Caro, Aarushi Audhut \| Kempeneers, Julie \| Ceusters, Jolien \| Thirion, Gitte \| Vandenbrande, Katja \| Vergote, Ignace \| Laoui, Damya \| Coosemans, An Cancers, volume 16, issue 6, pages 1147- (2024). 10.3390/cancers16061147 Cite \| Source
778 Predictive value of whole-body diffusion-weighted MRI in the preoperative assessment of advanced ovarian cancer after neo-adjuvant chemotherapy (conference) Vandecaveye, Vincent \| Dresen, Raphaëla Carmen \| Broeckhoven, Valerie \| Baert, Thaïs \| Nieuwenhuysen, Els Van \| Dekezyer, Frederik \| Gorp, Toon Van \| Vergote, Ignace ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.712 Cite \| Source
907 Ovarian function after ovarian transposition prior to pelvic radiotherapy. A retrospective study (conference) Missotten, Charlotte \| Christiaens, Melissa \| Gorp, Toon Van \| Nieuwenhuysen, Els Van \| Baert, Thaïs \| Vergote, Ignace \| Limbergen, Erik Van \| Hompes, Daphne \| Han, Sileny ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.474 Cite \| Source
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study (conference) Sehouli, Jalid \| Vergote, Ignace \| Hamilton, Erika \| Fidalgo, Alejandro Pérez \| Gorp, Toon Van \| Scambia, Giovanni \| Klat, Jaroslav \| Levy, Tally \| Welch, Stephen \| Richardson, Debra L \| ... \| Makker, Vicky ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.20 Cited by (2) \| Cite \| Source
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first, do no harm (journal article) Chiva, Luis \| Vergote, Ignace International Journal of Gynecologic Cancer, volume 34, issue 1, pages 10-11 (2024). 10.1136/ijgc-2023-005148 Cited by (1) \| Cite \| Source
Selinexor in patients with advanced and recurrent endometrial cancer (journal article) Bogani, Giorgio \| Monk, Bradley J \| Coleman, Robert L \| Vergote, Ignace \| Oakin, Ana \| Ray-Coquard, Isabelle \| Mariani, Andrea \| Scambia, Giovanni \| Raspagliesi, Francesco \| Bolognese, Bruno Current Problems in Cancer, volume 47, issue 6, pages 100963- (2023). 10.1016/j.currproblcancer.2023.100963 Cited by (7) \| Cite \| Source
Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial (journal article) Arends, Christopher Maximilian \| Kopp, Klara \| Estrada-Barreras, Natalia \| Hablesreiter, Raphael \| Concin, Nicole \| Moll, Ute \| Zeilinger, Robert \| Schmitt, Wolfgang \| Sehouli, Jalid \| Kulbe, Hagen \| ... \| Damm, Frederik Blood, volume 142, issue Supplement 1, pages 1317-1317 (2023). 10.1182/blood-2023-184768 Cite \| Source
PO006LBA/#1520 Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study (conference) Scambia, Giovanni \| Vergote, Ignace \| Hamilton, Erika \| Fidalgo, Jose Perez \| Gorp, Toon Van \| Sehouli, Jalid \| Klat, Jaroslav \| Levy, Tally \| Welch, Stephen \| Richardson, Debra \| ... \| Makker, Vicky IGCS 2023 Annual Meeting Abstracts (2023) 10.1136/ijgc-2023-IGCS.6 Cite \| Source
TP010/#397 ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma (conference) Vergote, Ignace \| Mirza, Mansoor Raza \| Coleman, Robert \| Fidalgo, Jose Perez \| Monk, Bradley \| Valabrega, Giorgio \| Slomovitz, Brian \| Gorp, Toon Van \| Moore, Kathleen \| Sehouli, Jalid \| ... \| Makker, Vicky IGCS 2023 Annual Meeting Abstracts (2023) 10.1136/ijgc-2023-IGCS.472 Cite \| Source
New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables! (journal article) Vergote, Ignace \| Matias-Guiu, Xavier European Journal of Cancer, volume 193 (2023). 10.1016/j.ejca.2023.113318 Cited by (7) \| Cite \| Source